Vistagen Stock: Initial Analysis Of Fasedienol Points To Bullish (NASDAQ:VTGN)

allanswart Vistagen Therapeutics (NASDAQ:VTGN) has proprietary platform technologies to discover and develop drugs that could redefine the treatment of mental health disorders. With a potential NDA-enabling Phase III program already funded, Vistagen is approaching some significant milestones that could be potent catalysts for the ticker. Moreover, the company’s deep pipeline of neuroscience candidates, each targeting…

Read More

Salesforce to Hire 3300 Workers After Initial Employee Layoffs

According to CEO, the company needs to employ “thousands” of people to maintain its growth potential and margins. Cloud-based software firm, Salesforce, is planning to boost its employee numbers by hiring 3,300 specialists. Chief Executive Marc Benioff revealed this while speaking to Bloomberg at the company’s annual Dreamforce conference. The announcement follows the company’s decision…

Read More

Rentokil Initial: Thriving Compounder In A Market Leading Position (NYSE:RTO)

Dan Kitwood/Getty Images News Investment thesis Our current investment thesis is Rentokil Initial plc (NYSE:RTO) (OTCPK:RKLIF) is an incredibly attractive business, with a market-leading position in various essential services segments globally. This is developed through scale and deep expertise, allowing the company to create long-term relationships with clients. The company’s strategy of bolt-on M&A has…

Read More